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Abstract
Objective—Schizophrenia is a neurodevelopmental disorder associated with abnormalities of
brain structure and white matter, although little is known about when these abnormalities arise.
This study was conducted to identify structural brain abnormalities in the prenatal and neonatal
periods associated with genetic risk for schizophrenia.
Method—Prenatal ultrasound scans and neonatal structural magnetic resonance imaging (MRI)
and diffusion tensor imaging were prospectively obtained in the offspring of mothers with
schizophrenia or schizoaffective disorder (N=26) and matched comparison mothers without
psychiatric illness (N=26). Comparisons were made for prenatal lateral ventricle width and head
circumference, for neonatal intracranial, CSF, gray matter, white matter, and lateral ventricle
volumes, and for neonatal diffusion properties of the genu and splenium of the corpus callosum
and corticospinal tracts.
Results—Relative to the matched comparison subjects, the offspring of mothers with
schizophrenia did not differ in prenatal lateral ventricle width or head circumference. Overall, the
high-risk neonates had nonsignificantly larger intracranial, CSF, and lateral ventricle volumes.
Subgroup analysis revealed that male high-risk infants had significantly larger intracranial, CSF,
total gray matter, and lateral ventricle volumes; the female high-risk neonates were similar to the
female comparison subjects. There were no group differences in white matter diffusion tensor
properties.
Conclusions—Male neonates at genetic risk for schizophrenia had several larger than normal
brain volumes, while females did not. To the authors' knowledge, this study provides the first
evidence, in the context of its limitations, that early neonatal brain development may be abnormal
in males at genetic risk for schizophrenia.
Schizophrenia has been considered a neurodevelopmental disorder for more than 20 years
(1, 2). This conceptualization is based on observations that schizophrenia is associated with
a variety of pre- and perinatal environmental insults to the developing brain, including
infection and obstetric and birth complications (3). In addition, children who ultimately
develop schizophrenia exhibit a variety of subtle developmental and neurocognitive
abnormalities, including delayed motor milestones, speech problems, lower educational test
scores (4), and deficits in verbal memory, attention, motor skills, and receptive language (5,
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6). Finally, many of the genes that may increase risk of developing schizophrenia regulate
multiple processes important in brain development (7, 8).
Schizophrenia is associated with subtle abnormalities of brain structure, including larger
than normal lateral ventricles, lower cortical gray matter volumes, and lower hippocampal
volumes (9). In general, these structural abnormalities are present at the first episode,
suggesting that they may precede the onset of clinical symptoms (10). More recent diffusion
tensor imaging studies also indicate that abnormalities of white matter are present in
schizophrenia (11) and that they appear to be present at the first episode as well (12).
Structural brain abnormalities have also been observed in the unaffected relatives of
individuals with schizophrenia. Unaffected co-twins exhibit cortical structure abnormalities
that are similar to, but less severe than, those of the affected twins. These abnormalities
include low brain volume, larger than normal lateral ventricles (13), and low gray matter
volumes in the prefrontal cortex (14). Similar studies in unaffected siblings also suggest a
structural endophenotype of low cortical gray matter volume associated with genetic risk
(15–18), although this is not a consistent finding (19, 20). Adolescents and young adults at
genetic risk for schizophrenia also have evidence of low prefrontal lobe volume (21) and
low gray matter density in the cingulate and the temporal and right frontal lobes (22), as well
as abnormalities of white matter as shown by diffusion tensor imaging (23).
There is evidence of subtle brain structure endophenotypes associated with genetic risk for
schizophrenia in adults, although it is not clear when in the course of development these
endophenotypes arise. Studies of the unaffected siblings of children with early-onset
schizophrenia do show smaller than normal cortical gray matter that tends to normalize in
adolescence (24), suggesting that endophenotypes of genetic risk are present in childhood.
Understanding of the timing of structural abnormalities would allow a better identification
of neurodevelopmental processes that contribute to risk for schizophrenia. To learn more
about the timing in individuals with high genetic risk, we prospectively studied prenatal
brain structure with ultrasound and neonatal brain structure with magnetic resonance
imaging (MRI), including diffusion tensor imaging, in the children of mothers with
schizophrenia and matched comparison subjects. We hypothesized that at-risk infants would
have larger lateral ventricle volumes, lower cortical gray matter volumes, and evidence of
dysmaturation of major white matter tracts in relation to the comparison subjects.
Method
Participants
This study was approved by the institutional review board of the University of North
Carolina School of Medicine. Women with schizophrenia or schizoaffective disorder who
were pregnant were recruited from inpatient psychiatric units and outpatient clinics in
central North Carolina. Subjects were asked by their treating psychiatrist or social worker if
they were interested in the study, and if they were, a study coordinator met with the patient
and told her more about the study. Active substance abuse was an exclusion criterion for
both the patients and comparison subjects. The matched comparison subjects were selected
from a companion study of normal brain development; for this study, pregnant women
without psychiatric illness, major medical illness, pregnancy complications, or abnormality
shown by prenatal ultrasound were recruited by flyer from the Prenatal Diagnostic Clinic at
University of North Carolina Hospitals. Mothers with schizophrenia underwent a Structured
Clinical Interview for DSM-IV Axis I Disorders (SCID), and past psychiatric records were
obtained; a final consensus diagnosis was assigned. Potential comparison mothers were
screened for psychiatric illness by using a modified SCID. Comparison infants were
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matched on gender, age in terms of time since last menstrual period at birth, age since the
last menstrual period at MRI, and maternal age.
Prenatal Ultrasound
Ultrasound scans obtained at approximately 22 and 32 weeks after the last menstrual period
were performed by trained study ultrasonographers on an ATL 5000 (Philips Medical
Systems, Andover, Mass.) or Voluson Expert (GE Healthcare, Waukesha, Wis.). Head
circumference was measured in a horizontal plane by using standard landmarks; the
ventricle width was determined at the atrium of the lateral ventricle at the tail of the choroid,
with measurement from inner wall to inner wall (25). The width of the ventricle farthest
from the transducer was measured twice and averaged for each visit.
MR Image Acquisition
Images were acquired on a Siemens head-only 3-T scanner (Allegra, Siemens Medical
Solutions, Erlangen, Germany). Neonates were scanned unsedated during natural sleep; they
were fed prior to scanning, swaddled, and fitted with ear protection, and their heads were
secured in a vacuum-fixation device. A physician or nurse was present during each scan; a
pulse oximeter was used to monitor heart rate and oxygen saturation. In the initial phase of
the study, T1-weighted structural pulse sequences were obtained for seven infants (four in
the high-risk group, three in the comparison group) with a three-dimensional T1-weighted
fast low-angle shot sequence (TR=15 msec, TE=7 msec, flip angle=25°); then a three-
dimensional magnetization prepared rapid gradient echo sequence was used for 57 neonates
(TR=1,820 msec, TI=400 msec, TE=4.38 msec, flip angle=7°). Proton density and T2-
weighted images were obtained with a turbo spin echo sequence (TR=6,200 msec, TE1=20
msec, TE2=119 msec, flip angle=150°). The spatial resolution that was used provided a
1×1×1-mm voxel for the T1-weighted images and a 1.25×1.25×1.50-mm voxel with a 0.5-
mm interslice gap for the proton density and T2-weighted images. For one neonate in the
high-risk group early in the study, a lower-resolution T2 sequence was used (turbo spin echo
sequence: TR=7,000 msec, TE1=18 msec, TE2=108 msec, flip angle=150°) with a 1×1×3-
mm voxel size and a 0.9-mm interslice gap.
A single shot echo planar spin echo diffusion tensor imaging sequence was used with the
following variables: TR=5,200 msec, TE=73 msec, slice thickness=2 mm, in-plane
resolution=2×2 mm2, and 45 slices. Seven images were acquired for each slice, one without
diffusion gradient (b=0) and the remaining six with b=1,000 sec/mm2 and diffusion
gradients along {1/√2, 0, 1/√2}, {−1/√2, 0, 1/√2}, {0, 1/√2, 1/√2}, {0, 1/√2, −1/√2}, {1/√2, 1/
√2, 0}, {−1/√2, 1/√2, 0}, separately. In order to improve the signal-to-noise ratio for the
diffusion tensor images, five separate sets of images with two averages in each set were
acquired. This approach shortens data acquisition time (1.18 minutes/set) and minimizes
motion artifacts.
Segmentation and Lobe Parcellation Analysis
Brain tissue was automatically classified as gray matter, unmye linated white matter,
myelinated white matter, and CSF by using an atlas-moderated iterative expectation
maximization segmentation algorithm based on both T1 and T2 scans as previously
described (26) (Figure 1). Five subjects in the high-risk group had a T2 scan only; these
segmentations were compared to the results derived from the T2 scan of the matched
comparison subjects. Overall results were similar for all analyses when the T2-only subjects
were excluded. Parcellation of the cortex into anatomical regions (frontal, prefrontal,
parietal, and occipital) was achieved by nonlinear warping of a parcellation atlas template as
previously described (26). Left and right hemispheres were subdivided into four regions
along the anterior-posterior axis (prefrontal, frontal, parietal, occipital) and into infra- and
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supratentorial regions (Figure 1). The cerebellum, brainstem, and combined sets of
subcortical structures are represented separately.
The volume of the lateral ventricles was segmented with a user-supervised, highly
automated level-set evolution tool, itk- SNAP (27). Left and right lateral ventricles were
separated by a three-dimensional cutting tool. Intracranial volume was defined as the sum of
the automatic full-brain segmentation results for gray matter, white matter, and CSF
(ventricles and subarachnoid space) volumes.
Diffusion Tensor Analysis
Each individual directional gradient image was screened offline for motion artifacts by using
an automatic diffusion tensor analysis quality control tool (DTIchecker) that calculates an
average of the five repeated sequences after correction for motion and removal of outliers
(28). Quantitative analysis of fiber tracts was accomplished by using a set of tools for
computation of fractional anisotropy and mean diffusivity maps, quantitative tractography,
fiber clustering, and parametrization as previously described (28). Tracts are initialized by
drawing source and target regions of interest on fractional anisotropy images. The fiber
tracking tool (FiberViewer; software download at http://www.ia.unc.edu/dev) reads the set
of diffusion image channels, calculates the tensor field, reads the region of interest image,
and performs the tracking. The resulting sets of streamlines are stored as list of polylines,
which carry the full tensor information at each location. Cross-sectional regions of interest
were defined in the left (21 mm) and right (−21 mm) cortical and central regions of the genu
of the corpus callosum, in the left (24 mm) and right (−24 mm) cortical and central (0 mm)
regions of the splenium of the corpus callosum, and in cortical (9 mm) and central (−12)
regions of the left and right corticospinal tracts as previously described (28) (Figure 1).
Statistical Analysis
For baseline categorical variables, frequency distributions were calculated for categorical
variables, and means and standard deviations were calculated for continuous variables.
Differences between groups at baseline for continuous variables were assessed by means of t
tests.
For examination of differences between the risk groups (high risk versus comparison) in the
measurements of the regions of interest at the second trimester and third trimester, we used
mixed models. We fit separate models for the second and third trimesters because many of
the subjects were measured at only one of the time points. We report least squares means
and standard errors along with a contrast examining the difference between the comparison
and high-risk groups on these least squares means.
For a given region of interest at a given time point, the model included the block as a
random effect and risk group as a fixed effect. Differences in least squares means were
assessed through contrasts. The denominator value for degrees of freedom was calculated by
using the Kenward and Roger method.
Results
Forty-seven women with psychosis were enrolled between May 2003 and December 2008.
Four were excluded for having diagnoses other than schizophrenia and schizoaffective
disorder, nine were lost to follow-up before the neonatal MRI, three refused the neonatal
MRI, one experienced fetal demise, and four did not complete the MRI scan. Thus, the final
study group included 26 women with schizophrenia or schizoaffective disorder and 26
matched comparison subjects. Diffusion tensor imaging scans were obtained for 19 of the
women with schizophrenia or schizoaffective disorder. Second- and third-trimester
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ultrasounds were obtained for 11 and 16, respectively. Among the ill women, there was one
set of twins and three sets of siblings. Analyses were run with and without these related
high-risk subjects; the findings were not influenced by inclusion or exclusion of these
subjects.
Table 1 summarizes the sociodemographic variables for the comparison and high-risk
groups. There was a significant difference in maternal education between the groups;
otherwise the groups were comparable. Table 2 summarizes the medication and substance
exposure, as well as maternal medical problems and obstetric and perinatal complications.
Twenty-three of the 26 high-risk infants had prenatal exposure to an antipsychotic; no
comparison infants had antipsychotic exposure. The high-risk infants were also more likely
to have been exposed to antidepressants and cigarette smoking during pregnancy. MRI scans
showed that two high-risk and six comparison infants had small intracranial hemorrhages,
which are common in the neonatal period and probably related to the birth process (29).
Prenatal Ultrasound
Ultrasound recordings were obtained for 11 matched pairs (five male and six female infants
per group) in the second trimester. As shown by F tests for difference, there were no
significant differences between the high-risk and comparison infants in either lateral
ventricle width (least squares mean=0.55 [SE=0.04] versus 0.49 [SE=0.04] cm, p=0.23) or
head circumference (least squares mean=20.16 [SE=0.78] versus 19.82 [SE=0.78] cm,
p=0.77). Ultrasound recordings were obtained for 16 matched pairs (six male and 10 female
infants per group) in the third trimester. There were no significant differences between the
highrisk and comparison infants in either lateral ventricle width (least squares mean=0.46
[SE=0.04] versus 0.50 [SE=0.04] cm, p=0.56), although the high-risk infants had a
nonsignificantly larger head circumference (least squares mean=30.08 [SE=0.36] versus
29.20 [SE=0.36] cm, p=0.10).
Structural MRI
There were no significant group differences in the intracranial, lateral ventricle, and
cerebellum volumes or in any tissue volume (Table 3). The genetically high-risk infants did
have larger intracranial, CSF, and lateral ventricle volumes, although these differences did
not reach statistical significance. Controlling for intracranial volume did not reveal any
group differences for any analysis. There were no group differences for gray or white matter
volume in any cortical region (online data supplement).
In a secondary analysis, we explored volume differences by gender. The male high-risk
infants had significantly larger intracranial volumes than the male comparison infants, as
well as significantly larger total gray matter, total CSF, cortical gray matter, and lateral
ventricle volumes (Table 4). These differences were not significant when adjusted for
intracranial volume (online data supplement). There were no group differences for
intracranial volume or any other tissue volume in the female infants. We also explored the
effect of maternal smoking on brain volumes in the high-risk group; there were no
significant differences in any brain volume between exposed and nonexposed neonates (data
not shown).
Diffusion Tensor Imaging Tractography
Diffusion tensor imaging scans were obtained for 19 matched pairs (six male and 13 female
infants per group). There were no group differences in fractional anisotropy or mean
diffusivity for any region in the genu and splenium of the corpus callosum or in the left and
right corticospinal tracts (Table 5).
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To our knowledge, this is the first study of neonatal brain structure in children at high
genetic risk for schizophrenia. And while this study has limitations, we unexpectedly found
that male high-risk neonates have significantly larger intracranial, CSF, gray matter, and
lateral ventricle volumes than male comparison infants, while female high-risk neonates
have brain volumes similar to those of female comparison infants. Our findings suggest that
prenatal and early neonatal brain development is abnormal in males at genetic risk for
schizophrenia and that some brain structure endophenotypes associated with risk for
schizophrenia may be present at birth.
Schizophrenia is increasingly considered a disorder of cortical connectivity, evidenced by
lower than normal levels of cortical synaptic markers (30), spine density (31), and dendritic
complexity (32) in postmortem studies and by low gray matter volume in imaging studies. It
is unclear when the abnormalities observed in patients with schizophrenia or their unaffected
first-degree relatives arise. In the human cortex, synapse development occurs rapidly in the
first years of life; the number of synapses plateaus prior to puberty and then regresses after
puberty (33, 34). This general pattern is evident in the development of cortical gray matter
volume, which increases rapidly in the first 2 years of life (26, 35) and decreases after
puberty (36). Our finding of larger cortical gray matter volumes in male neonates at risk for
schizophrenia suggests that abnormalities of gray matter may arise early in brain
development. In the first 2 years of life, there is enormous growth of cortical gray matter,
which increases 185% from birth (35). This period of rapid growth of synaptic connections
and dendritic complexity would seem a likely period in which gray matter abnormalities
might become evident in high-risk children.
There is evidence in our study that male high-risk children have larger brains than
comparison subjects. This is a somewhat unexpected finding and must be considered in light
of the small number of subjects. However, this pattern of enlargement is somewhat
reminiscent of the larger neonatal brain volumes, especially larger gray matter volumes
associated with larger lateral ventricle volumes, observed in children with prenatal mild
ventriculomegaly (37). The larger cortical gray matter volumes are also reminiscent of the
macrocephaly observed in autism (38), perhaps implicating similar early developmental
trajectories in these disorders, which have some overlapping behavioral features. A recent
twin study we conducted indicates that in the neonatal period, the heritability of gray matter
volume is 0.56, less than that observed in adults, while the heritability of lateral ventricle
volume is 0.71, higher than that observed in adults (39). The larger gray matter volumes
observed in this cohort may reflect genetic and environmental risk factors, while the
enlarged ventricles may reflect more genetic risk.
It is tempting to speculate that in some forms of schizophrenia, larger than normal neonatal
gray matter is an early indication of abnormal connectivity in the developing cortex, an
abnormal connectivity that persists throughout brain development and may ultimately result
in low cortical gray matter volumes as developmental trajectories play out over childhood.
For example, low gray matter volumes are seen not only in adults with schizophrenia but
also in children with early-onset schizophrenia (24). Of course, much larger groups and
longitudinal studies are needed to determine this with any certainty. Adolescence, a period
of significant synaptic reorganization and elimination (33, 34), also represents another
period of brain development and a period in which abnormalities in gray matter may likely
emerge. Alternatively, gray matter abnormalities could also occur after the onset and during
the course of the illness (36). This question turns on whether gray matter abnormalities
occur as a consequence of altered neurodevelopment or pathophysiologic processes inherent
in the disorder.
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Several of the genes that may increase risk for schizophrenia, including NRG1, erbB4,
DISC1, and DTNBP1, have roles in synapse development and plasticity (7, 8), the effects of
which might become apparent in the period of rapid postnatal synapse development. Finally,
studies in twins suggest that the heritability of gray matter volume increases with age (39),
additional evidence that genetic effects on gray matter development would become more
evident through postnatal brain development.
Diffusion tensor imaging has revealed widespread abnormalities of white matter in people
with schizophrenia and those at genetic high risk; these abnormalities include major white
matter tracts of the corpus callosum and internal capsule (11, 12). We detected no group
differences in diffusion tensor imaging properties in any of the white matter tracts studied.
This suggests that white matter abnormalities may emerge after the neonatal period. It
appears that major white matter tracts are established at birth, while myelination and
maturation of diffusion properties in these tracts occur rapidly over the first 2 years of life,
with a more gradual attainment of adult levels thereafter (28, 40, 41). The first 2 years of
life, with their rapid growth and maturation, may be a period when white matter
abnormalities associated with schizophrenia risk emerge.
A previous retrospective prenatal ultrasound study showed that lateral ventricle width in the
offspring of mothers with schizophrenia was not greater than normal (42). We found no
differences in prenatal ventricle width, supporting the findings of Clarke et al. (42), although
we did find larger than normal neonatal ventricle volume in males. This suggests that the
higher lateral ventricle volume observed in high-risk neonates may arise after the 32-week
ultrasound or that the two-dimensional ultrasound is not a sensitive measure of prenatal
lateral ventricle volume.
This study has several limitations. While the number of subjects is large in terms of the
difficulty in recruiting and imaging this high-risk group, it is small given the heterogeneity
of schizophrenia (and risk for schizophrenia) and the relative inconsistencies of imaging
findings in older subjects. With our study group size, we had 0.8 power to detect differences
in gray matter volume of about 10% (43). The magnitude of volume differences in adults
with schizophrenia is typically less than 10%, and it is even less in studies of unaffected
siblings at genetic risk. Most of the mothers of the high-risk subjects in this study took
antipsychotics during pregnancy. Previous studies have shown that antipsychotics do not
appear to significantly increase the risk of malformations or significant pregnancy outcomes
(44), and studies in nonhuman primates suggest that chronic antipsychotic exposure can
decrease cortical gray matter volumes (45), although the effect of antipsychotics on prenatal
cortical development in humans is unknown. Our finding of no large differences in neonatal
brain structure or white matter integrity in the female offspring of mothers with
schizophrenia suggests that antipsychotics during pregnancy do not have a major impact on
brain structure, although gender-specific effects cannot be ruled out. The mothers with
schizophrenia were also more likely to have smoked tobacco and to have used illicit
substances during pregnancy, and each of these factors could have confounded the results,
although the expected direction of effects would be toward smaller overall head and brain
sizes (46). As already noted, we did not find significant differences in volumes between the
high-risk neonates exposed to maternal smoking and those who were not exposed.
Otherwise, the high-risk and comparison groups were reasonably well matched for pre- and
perinatal factors. The absence of detectable abnormalities in the female high-risk neonates in
this study does not mean prenatal brain development is normal, as more subtle, undetectable
differences in gray and white matter development may be present. Finally, we would expect
only about 10% of the high-risk neonates to ultimately develop schizophrenia, although
observed abnormalities may represent intermediate phenotypes of risk.
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In summary, male neonates at high risk for schizophrenia appear to have larger than normal
gray matter, CSF, and lateral ventricle volumes, and this appears to be the first evidence that
neonatal brain development is abnormal in individuals at genetic risk for schizophrenia. It is
suggested that the period of rapid cortical synapse development and gray matter volume
growth in the first 2 years of postnatal life represents an important period in which the
abnormalities of “connectivity” thought to underlie risk for schizophrenia may emerge.
Neuropsychological studies of children genetically at risk for schizophrenia have revealed a
variety of neuropsychological and motor abnormalities that are apparent early in life (47–
49); the structural abnormalities that underlie them may also arise in the first years of life.
We are following this cohort through this period of rapid postnatal brain development to
study how these structural brain abnormalities progress after birth.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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FIGURE 1. Representative MRI Images and Image Analysis of Brain Structure in Infants at
High Genetic Risk for Schizophreniaa
aPart A is a T2-weighted image with tissue segmented into CSF (yellow), gray matter (blue),
unmyelinated white matter (green), and myelinated white matter (red). Part B displays the
regional parcellation; see text for details. Part C is a fractional anisotropy image. Part D
displays the white matter tractography involving the genu of the corpus callosum (G),
splenium of the corpus callosum (S), and corticospinal tract (CS).
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TABLE 1
Demographic Characteristics of Infants at High Genetic Risk for Schizophrenia and Comparison Infants
Characteristic Comparison Infants High-Risk Infants
N % N %
Gender
 Male 12 46.2 12 46.2
 Female 14 53.8 14 53.8
Ethnicity
 Caucasian 17 65.4 12 46.2
 African American 9 34.6 13 50.0
 Other 0 0.0 1 3.8
Mean SD Mean SD
Maternal age (years) 27.9 4.5 29.0 4.0
Infant age (weeks since mother's last menstrual period)
 At ultrasound 1 (approximately 22 weeks after last menstrual period) 22.0 1.1 22.3 3.0
 At ultrasound 2 (approximately 32 weeks after last menstrual period) 32.0 1.1 32.4 0.8
 At birth 38.5 2.3 38.1 3.1
 At MRI 42.6 2.4 43.2 3.3
Birth weight (g) 3112.2 596.3 3179.1 916.4
Maternal education (years)a 14.2 2.7 10.0 3.6
a
Significant difference between groups (t=4.74, df=50, p<0.0001).
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TABLE 2
Pre- and Perinatal Conditions of Infants at High Genetic Risk for Schizophrenia and Comparison Infants
Pre- or Perinatal Condition Number of Comparison Infants(N=26)
Number of High-Risk Infants
(N=26) Fisher's Exact Test (p)
Maternal medical problems
 Gestational diabetes 2 6a 0.25
 Asthma 2 2 1.00
 Seizure disorder 0 2 0.40
 Hypertension 1 2 1.00
 Hypothyroidism 1 1 1.00
 Sickle cell trait 1 0 1.00
 Infectionb 10 17 0.10
Medication exposure
 Antipsychoticc 0 23 <0.0001
 Antidepressantd 0 8 0.0005
 Lithium 0 2 0.50
 Other medication 16 18 0.78
Substance exposure
 Tobacco smoking 1 12 <0.0001
 Alcohol 0 3 0.24
 Marijuana 0 4 0.14
Caesarean section 7 12 0.25
Premature birth (<37 weeks) 8 7 1.00
Stay in neonatal intensive care unit 2 6 0.25
a
Mother of twins counted twice.
b
Any infection during pregnancy: vaginal, urinary tract, upper respiratory, or other.
c
Thirteen high-risk infants had exposure to a single antipsychotic: haloperidol (N=7), aripiprazole (N=2), ziprasidone (N=2), olanzapine (N=1), or
quetiapine (N=1). Nine high-risk infants were exposed to two antipsychotics: haloperidol and risperidone (N=2), haloperidol and olanzapine (N=2),
haloperidol and quetiapine (N=1), haloperidol and aripiprazole (N=1), haloperidol and chlorpromazine (N=1), aripiprazole and risperidone (N=1),
or olanzapine and quetiapine (N=1). One high-risk infant was exposed to three antipsychotics: haloperidol, risperidone, and quetiapine.
d
Sertraline (N=5), citalopram (N=1), paroxetine (N=1), or escitalopram (N=1).




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Am J Psychiatry. Author manuscript; available in PMC 2011 September 1.
